Enox Biopharma Inc (N/A)

Not featured in screeners

Not featured in screeners

Ticker: N/A

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

David Itamar

Chief Financial Officer

1 purchase — total 50,000 USD

Buy 12 Aug 2010

Value US$4,983,336.56 | Price 70.31 | Shares 90,560

Avniel Amir

Chairman of the Board

1 purchase — total 50,000 USD

Buy 12 Aug 2010

Value US$3,847,779.41 | Price 45.98 | Shares 42,861

David Itamar

Chief Financial Officer

1 purchase — total 60,337 USD

Buy 15 Jul 2010

Value US$60,336.60 | Price 0.30 | Shares 201,122

Av-Gay Yossef

President

1 purchase — total 10,001 USD

Buy 2 Nov 2009

Value US$10,000.65 | Price 0.12 | Shares 80,846

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2010-08-18	2010-08-12	B Purchase	David Itamar Chief Financial Officer Officer	90,560 +7.5% 70.31 US$4,983,337	90,560 +7.5%	70.31	US$4,983,337
2010-08-18	2010-08-12	B Purchase	Avniel Amir Chairman of the Board Executive Director Large shareholder	42,861 -44.1% 45.98 US$3,847,779	42,861 -44.1%	45.98	US$3,847,779
2010-08-18	2010-07-15	B Purchase	David Itamar Chief Financial Officer Officer	91,511 -31.9% 86.52 US$525,071	91,511 -31.9%	86.52	US$525,071
2009-11-04	2009-11-02	B Purchase	Av-Gay Yossef President Executive Director Large shareholder	80,846 +1.5% 0.12 US$10,001	80,846 +1.5%	0.12	US$10,001

More insider trading research around Enox Biopharma Inc